Importantly, clinical trials have not demonstrated an increased risk of hypoglycemia with GLP-1 RAs compared to placebo ( While some studies have suggested a possible association between GLP-1 RAs and acute kidney injury (AKI), this has not been confirmed and appears to occur primarily in patients with underlying risk factors such as dehydration or severe gastrointestinal symptoms (49)
GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in animal studies, and while the relevance to humans remains uncertain, patients with personal or family history of medullary thyroid carcinoma should not use these medications
We also examined if diet standardization the days prior to the test days influenced the results
Potential Risk of Thyroid Tumors Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 are expected to be contraindicated based on the drugs structural similarity to existing GLP-1 agents
and higher perceived financial and opportunity costs of many health-promoting foods have each contributed to a dearth of nutrition and culinary knowledge and competencies [[248], [249], [250]]
However, Sarwer noted that physiological senses like taste can vary a lot from person to person at baseline
